| Year |
Citation |
Score |
| 2023 |
Hassan MM, Li YD, Ma MW, Teng M, Byun WS, Puvar K, Lumpkin R, Sandoval B, Rutter JC, Jin CY, Wang MY, Xu S, Schmoker AM, Cheong H, Groendyke BJ, et al. Exploration of the Tunability of BRD4 Degradation by DCAF16 -labelling Covalent Glues. Biorxiv : the Preprint Server For Biology. PMID 37873358 DOI: 10.1101/2023.10.07.561308 |
0.582 |
|
| 2023 |
Miao Q, Kadam VD, Mukherjee A, Tan Z, Teng M. Unlocking DCAFs To Catalyze Degrader Development: An Arena for Innovative Approaches. Journal of Medicinal Chemistry. 66: 13369-13383. PMID 37738232 DOI: 10.1021/acs.jmedchem.3c01209 |
0.446 |
|
| 2023 |
Teng M, Gray NS. The rise of degrader drugs. Cell Chemical Biology. 30: 864-878. PMID 37494935 DOI: 10.1016/j.chembiol.2023.06.020 |
0.602 |
|
| 2023 |
Teng M, Jiang J, Wang ES, Geng Q, Toenjes ST, Donovan KA, Mageed N, Yue H, Nowak RP, Wang J, Manz TD, Fischer ES, Cantley LC, Gray NS. Targeting the Dark Lipid Kinase PIP4K2C with a Potent and Selective Binder and Degrader. Angewandte Chemie (International Ed. in English). e202302364. PMID 36898968 DOI: 10.1002/anie.202302364 |
0.571 |
|
| 2023 |
Li YD, Ma MW, Hassan MM, Hunkeler M, Teng M, Puvar K, Lumpkin R, Sandoval B, Jin CY, Ficarro SB, Wang MY, Xu S, Groendyke BJ, Sigua LH, Tavares I, et al. Template-assisted covalent modification of DCAF16 underlies activity of BRD4 molecular glue degraders. Biorxiv : the Preprint Server For Biology. PMID 36824856 DOI: 10.1101/2023.02.14.528208 |
0.551 |
|
| 2022 |
Teng M, Young DW, Tan Z. The Pursuit of Enzyme Activation: A Snapshot of the Gold Rush. Journal of Medicinal Chemistry. PMID 36265019 DOI: 10.1021/acs.jmedchem.2c01291 |
0.302 |
|
| 2022 |
Ye Q, Belabed H, Wang Y, Yu Z, Palaniappan M, Li JY, Kalovidouris SA, MacKenzie KR, Teng M, Young DW, Fujihara Y, Matzuk MM. Advancing ASMS with LC-MS/MS for the discovery of novel PDCL2 ligands from DNA-Encoded chemical library selections. Andrology. PMID 36209044 DOI: 10.1111/andr.13309 |
0.451 |
|
| 2022 |
Modukuri RK, Yu Z, Tan Z, Ta HM, Ucisik MN, Jin Z, Anglin JL, Sharma KL, Nyshadham P, Li F, Riehle K, Faver JC, Duong K, Nagarajan S, Simmons N, ... ... Teng M, et al. Discovery of potent BET bromodomain 1 stereoselective inhibitors using DNA-encoded chemical library selections. Proceedings of the National Academy of Sciences of the United States of America. 119: e2122506119. PMID 35622893 DOI: 10.1073/pnas.2122506119 |
0.538 |
|
| 2022 |
Teng M, Luskin MR, Cowan-Jacob SW, Ding Q, Fabbro D, Gray NS. The Dawn of Allosteric BCR-ABL1 Drugs: From a Phenotypic Screening Hit to an Approved Drug. Journal of Medicinal Chemistry. PMID 35609336 DOI: 10.1021/acs.jmedchem.2c00373 |
0.513 |
|
| 2021 |
Teng M, Lu W, Donovan KA, Sun J, Krupnick NM, Nowak RP, Li YD, Sperling AS, Zhang T, Ebert BL, Fischer ES, Gray NS. Development of PDE6D and CK1α Degraders through Chemical Derivatization of FPFT-2216. Journal of Medicinal Chemistry. PMID 34965125 DOI: 10.1021/acs.jmedchem.1c01832 |
0.627 |
|
| 2021 |
Vervoort SJ, Devlin JR, Kwiatkowski N, Teng M, Gray NS, Johnstone RW. Targeting transcription cycles in cancer. Nature Reviews. Cancer. 22: 5-24. PMID 34675395 DOI: 10.1038/s41568-021-00411-8 |
0.516 |
|
| 2021 |
Teng M, Jiang J, Ficarro SB, Seo HS, Bae JH, Donovan KA, Fischer ES, Zhang T, Dhe-Paganon S, Marto JA, Gray NS. Exploring Ligand-Directed -Acyl--alkylsulfonamide-Based Acylation Chemistry for Potential Targeted Degrader Development. Acs Medicinal Chemistry Letters. 12: 1302-1307. PMID 34413960 DOI: 10.1021/acsmedchemlett.1c00285 |
0.631 |
|
| 2021 |
Koduri V, Duplaquet L, Lampson BL, Wang AC, Sabet AH, Ishoey M, Paulk J, Teng M, Harris IS, Endress JE, Liu X, Dasilva E, Paulo JA, Briggs KJ, Doench JG, et al. Targeting oncoproteins with a positive selection assay for protein degraders. Science Advances. 7. PMID 33547076 DOI: 10.1126/sciadv.abd6263 |
0.7 |
|
| 2020 |
Donovan KA, Ferguson FM, Bushman JW, Eleuteri NA, Bhunia D, Ryu S, Tan L, Shi K, Yue H, Liu X, Dobrovolsky D, Jiang B, Wang J, Hao M, You I, ... Teng M, et al. Mapping the Degradable Kinome Provides a Resource for Expedited Degrader Development. Cell. PMID 33275901 DOI: 10.1016/j.cell.2020.10.038 |
0.491 |
|
| 2020 |
Teng M, Ficarro SB, Yoon H, Che J, Zhou J, Fischer ES, Marto JA, Zhang T, Gray NS. Rationally Designed Covalent BCL6 Inhibitor That Targets a Tyrosine Residue in the Homodimer Interface. Acs Medicinal Chemistry Letters. 11: 1269-1273. PMID 32551010 DOI: 10.1021/Acsmedchemlett.0C00111 |
0.632 |
|
| 2020 |
Gray NS, Teng M, Jiang J, He Z, Kwiatkowski NP, Donovan KA, Mills CE, Victor C, Hatcher JM, Fischer ES, Sorger PK, Zhang T. Development of CDK2 and CDK5 Dual Degrader TMX-2172. Angewandte Chemie (International Ed. in English). PMID 32415712 DOI: 10.1002/Anie.202004087 |
0.726 |
|
| 2019 |
Zhang T, Hatcher JM, Teng M, Gray NS, Kostic M. Recent Advances in Selective and Irreversible Covalent Ligand Development and Validation. Cell Chemical Biology. PMID 31631011 DOI: 10.1016/J.Chembiol.2019.09.012 |
0.722 |
|
| 2017 |
Teng M, Wu W, Li Z, Yang G, Qin J, Wang Y, Hu Z, Dong H, Hou L, Hu G, Shen L, Zhang Y, Li J, Chen S, Tian J, et al. Discovery of aminocyclohexene analogues as selective and orally bioavailable hNav1.7 inhibitors for analgesia. Bioorganic & Medicinal Chemistry Letters. PMID 29037948 DOI: 10.1016/j.bmcl.2017.10.010 |
0.369 |
|
| 2017 |
Wu W, Li Z, Yang G, Teng M, Qin J, Hu Z, Hou L, Shen L, Dong H, Zhang Y, Li J, Chen S, Tian J, Zhang J, Ye L. The discovery of tetrahydropyridine analogs as hNav1.7 selective inhibitors for analgesia. Bioorganic & Medicinal Chemistry Letters. PMID 28385504 DOI: 10.1016/j.bmcl.2017.03.043 |
0.426 |
|
| 2014 |
Teng M, Zi W, Ma D. Total synthesis of the monoterpenoid indole alkaloid (±)- aspidophylline A Angewandte Chemie - International Edition. 53: 1814-1817. PMID 24481917 DOI: 10.1002/Anie.201310928 |
0.657 |
|
| Show low-probability matches. |